Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Phathom Pharmaceuticals, Inc. (PHAT) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Phathom Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1783183.
Total stock buying since 2019: $45,761,252.
Total stock sales since 2019: $109,310,830.
Total stock option exercises since 2019: $167,915.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 71,983 | $243,324 | 32,365 | $208,739 | 0 | $0 |
| 2024 | 22,500 | $180,337 | 3,781,779 | $30,834,950 | 7,500 | $87,900 |
| 2023 | 41,419 | $323,415 | 29,981 | $259,621 | 0 | $0 |
| 2022 | 59,000 | $415,123 | 11,073 | $106,467 | 0 | $0 |
| 2021 | 0 | $0 | 2,241,557 | $71,467,195 | 11,513 | $80,015 |
| 2020 | 178,200 | $4,412,913 | 153,500 | $6,433,858 | 0 | $0 |
| 2019 | 2,115,060 | $40,186,140 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 1,692 | $14,151 | 0 | $0 |
| 2025-05 | 61,983 | $199,124 | 0 | $0 | 0 | $0 |
| 2025-04 | 0 | $0 | 3,678 | $16,738 | 0 | $0 |
| 2025-03 | 10,000 | $44,200 | 0 | $0 | 0 | $0 |
| 2025-01 | 0 | $0 | 26,995 | $177,850 | 0 | $0 |
| 2024-12 | 22,500 | $180,337 | 2,409 | $19,272 | 0 | $0 |
| 2024-09 | 0 | $0 | 0 | $0 | 7,500 | $87,900 |
| 2024-07 | 0 | $0 | 49,074 | $575,146 | 0 | $0 |
| 2024-04 | 0 | $0 | 3,435 | $38,128 | 0 | $0 |
| 2024-03 | 0 | $0 | 16,851 | $153,512 | 0 | $0 |
| 2024-01 | 0 | $0 | 3,710,010 | $30,048,892 | 0 | $0 |
| 2023-11 | 7,500 | $58,579 | 14,619 | $120,023 | 0 | $0 |
| 2023-06 | 0 | $0 | 1,960 | $22,367 | 0 | $0 |
| 2023-05 | 0 | $0 | 2,110 | $27,164 | 0 | $0 |
| 2023-04 | 23,919 | $191,176 | 3,439 | $25,001 | 0 | $0 |
| 2023-03 | 0 | $0 | 2,032 | $17,334 | 0 | $0 |
| 2023-02 | 5,000 | $38,660 | 0 | $0 | 0 | $0 |
| 2023-01 | 5,000 | $35,000 | 5,821 | $47,732 | 0 | $0 |
| 2022-11 | 0 | $0 | 11,055 | $106,125 | 0 | $0 |
| 2022-05 | 59,000 | $415,123 | 0 | $0 | 0 | $0 |
| 2022-03 | 0 | $0 | 18 | $342 | 0 | $0 |
| 2021-11 | 0 | $0 | 1,000,001 | $19,925,019 | 0 | $0 |
| 2021-10 | 0 | $0 | 18,000 | $586,395 | 0 | $0 |
| 2021-09 | 0 | $0 | 18,000 | $590,785 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-16 | Breedlove Robert Charles (Principal Accounting Officer) | Sale | 1,692 | 8.36 | 14,151 |
| 2025-05-21 | Topper James N | Buy | 3,780 | 3.87 | 14,609 |
| 2025-05-12 | Topper James N | Buy | 12,601 | 3.04 | 38,307 |
| 2025-05-09 | Topper James N | Buy | 35,602 | 3.40 | 121,224 |
| 2025-05-07 | Parikh Asit | Buy | 5,000 | 2.40 | 11,984 |
| 2025-05-06 | Parikh Asit | Buy | 5,000 | 2.60 | 13,000 |
| 2025-04-07 | Henderson Molly (CFO and CBO) | Sale | 3,678 | 4.55 | 16,738 |
| 2025-03-13 | Parikh Asit | Buy | 10,000 | 4.42 | 44,200 |
| 2025-01-21 | Nabulsi Azmi (Chief Operating Officer) | Sale | 7,886 | 6.59 | 51,960 |
| 2025-01-21 | Curran Terrie (President and Chief Executive) | Sale | 19,109 | 6.59 | 125,890 |
| 2024-12-19 | Nabulsi Azmi (Chief Operating Officer) | Sale | 1,118 | 8.00 | 8,944 |
| 2024-12-19 | Henderson Molly (CFO and CBO) | Sale | 1,291 | 8.00 | 10,328 |
| 2024-12-13 | Parikh Asit | Buy | 10,000 | 8.12 | 81,250 |
| 2024-12-13 | Karbe Frank | Buy | 12,500 | 7.93 | 99,087 |
| 2024-09-10 | Parikh Asit | Option Ex | 7,500 | 11.72 | 87,900 |
| 2024-07-15 | Nabulsi Azmi (Chief Operating Officer) | Sale | 10,901 | 11.72 | 127,759 |
| 2024-07-15 | Curran Terrie (President and Chief Executive) | Sale | 33,848 | 11.72 | 396,698 |
| 2024-07-15 | Henderson Molly (CFO and CBO) | Sale | 4,325 | 11.72 | 50,689 |
| 2024-04-08 | Henderson Molly (CFO and CBO) | Sale | 3,435 | 11.10 | 38,128 |
| 2024-03-22 | Curran Terrie (President and Chief Executive) | Sale | 16,851 | 9.11 | 153,512 |
| 2024-01-24 | Takeda Pharmaceutical Co Ltd (10% Owner) | Sale | 3,703,703 | 8.10 | 29,999,994 |
| 2024-01-19 | Henderson Molly (CFO and CBO) | Sale | 6,307 | 7.75 | 48,898 |
| 2023-11-20 | Henderson Molly (CFO and CBO) | Sale | 2,127 | 7.24 | 15,403 |
| 2023-11-08 | Parikh Asit (Director) | Buy | 2,500 | 7.80 | 19,500 |
| 2023-11-07 | Parikh Asit (Director) | Buy | 4,000 | 7.76 | 31,040 |
| 2023-11-06 | Parikh Asit (Director) | Buy | 1,000 | 8.04 | 8,039 |
| 2023-11-01 | Henderson Molly (CFO and CBO) | Sale | 12,492 | 8.38 | 104,620 |
| 2023-06-02 | Henderson Molly (CFO and CBO) | Sale | 1,960 | 11.41 | 22,367 |
| 2023-05-22 | Henderson Molly (CFO and CBO) | Sale | 2,110 | 12.87 | 27,164 |
| 2023-04-11 | Nabulsi Azmi (Chief Operating Officer) | Buy | 10,000 | 8.26 | 82,600 |
| 2023-04-10 | Parikh Asit (Director) | Buy | 1,000 | 7.55 | 7,550 |
| 2023-04-06 | Curran Terrie (President and Chief Executive) | Buy | 12,919 | 7.82 | 101,026 |
| 2023-04-06 | Henderson Molly (CFO and CBO) | Sale | 3,439 | 7.27 | 25,001 |
| 2023-03-01 | Henderson Molly (CFO and CBO) | Sale | 2,032 | 8.53 | 17,334 |
| 2023-02-13 | Parikh Asit (Director) | Buy | 5,000 | 7.73 | 38,660 |
| 2023-01-20 | Curran Terrie (President and Chief Executive) | Sale | 5,821 | 8.20 | 47,732 |
| 2023-01-12 | Parikh Asit (Director) | Buy | 5,000 | 7.00 | 35,000 |
| 2022-11-21 | Curran Terrie (President and Chief Executive) | Sale | 3,052 | 9.60 | 29,298 |
| 2022-11-21 | Henderson Molly (CFO and CBO) | Sale | 4,318 | 9.60 | 41,452 |
| 2022-05-16 | Nabulsi Azmi (Chief Operating Officer) | Buy | 20,000 | 8.16 | 163,280 |
| 2022-05-13 | Curran Terrie (President and Chief Executive) | Buy | 20,500 | 7.41 | 151,843 |
| 2022-05-13 | Henderson Molly (CFO and CBO) | Buy | 6,000 | .00 | 0 |
| 2022-05-12 | Parikh Asit (Director) | Buy | 12,500 | 8.00 | 100,000 |
| 2022-03-14 | Takeda Pharmaceutical Co Ltd | Sale | 18 | 19.00 | 342 |
| 2021-11-04 | Takeda Pharmaceutical Co Ltd | Sale | 1,000,001 | 19.93 | 19,925,019 |
| 2021-10-08 | Socks David A (Director) | Sale | 2,529 | 32.05 | 81,051 |
| 2021-10-07 | Socks David A (Director) | Sale | 15,471 | 32.66 | 505,344 |
| 2021-09-22 | Socks David A (Director) | Sale | 4,100 | 32.06 | 131,446 |
| 2021-09-21 | Socks David A (Director) | Sale | 13,900 | 33.05 | 459,339 |
| 2021-08-16 | Socks David A (Director) | Sale | 18,000 | 30.98 | 557,658 |
| 2021-07-07 | Takeda Pharmaceutical Co Ltd | Sale | 2,609 | 35.05 | 91,445 |
| 2021-07-02 | Takeda Pharmaceutical Co Ltd | Sale | 100 | 35.01 | 3,501 |
| 2021-07-01 | Takeda Pharmaceutical Co Ltd | Sale | 8,226 | 35.16 | 289,226 |
| 2021-06-28 | Takeda Pharmaceutical Co Ltd | Sale | 370 | 35.08 | 12,979 |
| 2021-06-25 | Takeda Pharmaceutical Co Ltd | Sale | 24,131 | 35.77 | 863,045 |
| 2021-06-22 | Takeda Pharmaceutical Co Ltd | Sale | 100 | 35.00 | 3,500 |
| 2021-06-21 | Takeda Pharmaceutical Co Ltd | Sale | 9,294 | 35.31 | 328,171 |
| 2021-06-18 | Takeda Pharmaceutical Co Ltd | Sale | 5,398 | 35.13 | 189,631 |
| 2021-06-17 | Takeda Pharmaceutical Co Ltd | Sale | 3,305 | 35.08 | 115,939 |
| 2021-06-14 | Takeda Pharmaceutical Co Ltd | Sale | 2,826 | 35.06 | 99,079 |
| 2021-06-08 | Takeda Pharmaceutical Co Ltd | Sale | 100 | 35.00 | 3,500 |
| 2021-06-07 | Takeda Pharmaceutical Co Ltd | Sale | 2,264 | 35.05 | 79,353 |
| 2021-06-02 | Takeda Pharmaceutical Co Ltd | Sale | 4,300 | 35.18 | 151,274 |
| 2021-06-01 | Takeda Pharmaceutical Co Ltd | Sale | 11,211 | 35.88 | 402,194 |
| 2021-05-28 | Takeda Pharmaceutical Co Ltd | Sale | 8,905 | 36.44 | 324,498 |
| 2021-05-25 | Takeda Pharmaceutical Co Ltd | Sale | 10,947 | 36.38 | 398,197 |
| 2021-05-24 | Takeda Pharmaceutical Co Ltd | Sale | 10,594 | 35.84 | 379,688 |
| 2021-05-21 | Takeda Pharmaceutical Co Ltd | Sale | 11,648 | 35.74 | 416,299 |
| 2021-05-20 | Takeda Pharmaceutical Co Ltd | Sale | 7,098 | 35.10 | 249,139 |
| 2021-05-20 | Socks David A (Director) | Sale | 3,482 | 34.65 | 120,665 |
| 2021-05-19 | Socks David A (Director) | Sale | 36,518 | 32.71 | 1,194,357 |
| 2021-05-14 | Takeda Pharmaceutical Co Ltd | Sale | 100 | 35.00 | 3,500 |
| 2021-05-13 | Takeda Pharmaceutical Co Ltd | Sale | 100 | 35.33 | 3,533 |
| 2021-05-12 | Takeda Pharmaceutical Co Ltd | Sale | 11,776 | 35.73 | 420,697 |
| 2021-05-07 | Takeda Pharmaceutical Co Ltd | Sale | 1,011 | 35.03 | 35,415 |
| 2021-05-06 | Takeda Pharmaceutical Co Ltd | Sale | 202 | 35.01 | 7,072 |
| 2021-05-05 | Takeda Pharmaceutical Co Ltd | Sale | 6,936 | 35.14 | 243,731 |
| 2021-05-04 | Takeda Pharmaceutical Co Ltd | Sale | 19,360 | 36.93 | 714,926 |
| 2021-05-03 | Takeda Pharmaceutical Co Ltd | Sale | 14,632 | 38.37 | 561,429 |
| 2021-04-06 | Socks David A (Director) | Sale | 17,882 | 36.58 | 654,195 |
| 2021-04-05 | Nabulsi Azmi (Chief Operating Officer) | Sale | 9,353 | 36.38 | 340,271 |
| 2021-04-05 | Socks David A (Director) | Sale | 22,118 | 36.41 | 805,404 |
| 2021-04-01 | Nabulsi Azmi (Chief Operating Officer) | Sale | 5,147 | 37.71 | 194,088 |
| 2021-03-22 | Curran Terrie (President and Chief Executive) | Sale | 11,513 | 43.66 | 502,657 |
| 2021-03-22 | Curran Terrie (President and Chief Executive) | Option Ex | 11,513 | 6.95 | 80,015 |
| 2021-03-12 | Socks David A (Director) | Sale | 500 | 46.67 | 23,335 |
| 2021-03-11 | Shah Rajeev M. | Sale | 710,000 | 43.75 | 31,062,500 |
| 2021-03-11 | Socks David A (Director) | Sale | 42,429 | 47.36 | 2,009,395 |
| 2021-03-10 | Socks David A (Director) | Sale | 12,071 | 49.09 | 592,553 |
| 2021-03-02 | Nabulsi Azmi (Chief Operating Officer) | Sale | 9,127 | 45.78 | 417,806 |
| 2021-03-01 | Nabulsi Azmi (Chief Operating Officer) | Sale | 5,373 | 45.91 | 246,685 |
| 2021-02-23 | Socks David A (Director) | Sale | 4,984 | 43.52 | 216,878 |
| 2021-02-22 | Socks David A (Director) | Sale | 20,140 | 46.09 | 928,313 |
| 2021-02-19 | Socks David A (Director) | Sale | 44,876 | 46.91 | 2,104,908 |
| 2021-02-02 | Nabulsi Azmi (Chief Operating Officer) | Sale | 9,084 | 40.84 | 370,954 |
| 2021-02-01 | Nabulsi Azmi (Chief Operating Officer) | Sale | 5,416 | 38.09 | 206,284 |
| 2021-01-12 | Socks David A (Director) | Sale | 27,165 | 35.96 | 976,880 |
| 2021-01-11 | Socks David A (Director) | Sale | 12,835 | 34.92 | 448,249 |
| 2020-12-17 | Socks David A (Director) | Sale | 48,212 | 41.31 | 1,991,493 |
| 2020-12-16 | Socks David A (Director) | Sale | 31,446 | 47.69 | 1,499,565 |
| 2020-12-02 | Nabulsi Azmi (Chief Operating Officer) | Sale | 7,302 | 45.31 | 330,853 |
| 2020-12-01 | Nabulsi Azmi (Chief Operating Officer) | Sale | 7,198 | 44.41 | 319,663 |
| 2020-11-11 | Socks David A (Director) | Sale | 6,877 | 39.25 | 269,942 |
| 2020-11-10 | Socks David A (Director) | Sale | 12,681 | 42.23 | 535,455 |
| 2020-11-09 | Socks David A (Director) | Sale | 10,784 | 42.87 | 462,320 |
| 2020-11-02 | Nabulsi Azmi (Chief Operating Officer) | Sale | 14,500 | 36.83 | 534,020 |
| 2020-04-01 | Shah Rajeev M. | Buy | 117,600 | 24.86 | 2,923,653 |
| 2020-03-31 | Shah Rajeev M. | Buy | 30,600 | 24.55 | 751,260 |
| 2020-03-27 | Shah Rajeev M. | Buy | 30,000 | 24.60 | 738,000 |
| 2020-01-05 | Nabulsi Azmi (Chief Operating Officer) | Sale | 1,854 | 33.77 | 62,607 |
| 2020-01-04 | Nabulsi Azmi (Chief Operating Officer) | Sale | 12,646 | 33.84 | 427,940 |
| 2019-10-29 | Edwards Jonathan S. (Director) | Buy | 1,052,631 | 19.00 | 19,999,989 |
| 2019-10-29 | Fhmls Ix, L.p. (10% Owner) | Buy | 1,052,631 | 19.00 | 19,999,989 |
| 2019-10-29 | Cola Michael F (Director) | Buy | 9,798 | 19.00 | 186,162 |
Insider trading activities including stock purchases, stock sales, and option exercises of PHAT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Phathom Pharmaceuticals, Inc. (symbol PHAT, CIK number 1783183) see the Securities and Exchange Commission (SEC) website.